Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study von Lampert, Erika J, Zimmer, Alexandra, Padget, Michelle, Cimino-Mathews, Ashley, Nair, Jayakumar R, Liu, Yingmiao, Swisher, Elizabeth M, Hodge, James W, Nixon, Andrew B, Nichols, Erin, Bagheri, Mohammad H, Levy, Elliott, Radke, Marc R, Lipkowitz, Stanley, Annunziata, Christina M, Taube, Janis M, Steinberg, Seth M, Lee, Jung-Min

Volltext

A multi‐institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancer von Kim, Richard D., Sanoff, Hanna K., Poklepovic, Andrew S., Soares, Heloisa, Kim, Jongphil, Lyu, Jing, Liu, Yingmiao, Nixon, Andrew B., Kim, Dae Won

Volltext

Vascular Endothelial Growth Factor Receptor 2 Controls Blood Pressure by Regulating Nitric Oxide Synthase Expression von Facemire, Carie S, Nixon, Andrew B, Griffiths, Robert, Hurwitz, Herbert, Coffman, Thomas M

Volltext

Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential? von Nixon, Andrew B., Schalper, Kurt A., Jacobs, Ira, Potluri, Shobha, Wang, I-Ming, Fleener, Catherine

Volltext

Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405 von Lipsyc-Sharf, Marla, Zhang, Sui, Ou, Fang-Shu, Ma, Chao, McCleary, Nadine Jackson, Niedzwiecki, Donna, Chang, I-Wen, Lenz, Heinz-Josef, Blanke, Charles D, Piawah, Sorbarikor, Van Loon, Katherine, Bainter, Tiffany M, Venook, Alan P, Mayer, Robert J, Fuchs, Charles S, Innocenti, Federico, Nixon, Andrew B, Goldberg, Richard, O’Reilly, Eileen M, Meyerhardt, Jeffrey A, Ng, Kimmie

Volltext

Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial von Clarke, Jeffrey M., Simon, George R., Mamdani, Hirva, Gu, Lin, Herndon, James E., Stinchcombe, Thomas E., Ready, Neal, Crawford, Jeffrey, Sonpavde, Guru, Balevic, Stephen, Nixon, Andrew B., Campa, Michael, Gottlin, Elizabeth B., Li, Huihua, Saxena, Ruchi, He, You Wen, Antonia, Scott, Patz, Edward F.

Volltext

Gene expression markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance) von Cushman, Stephanie M, Jiang, Chen, Hatch, Ace J, Shterev, Ivo, Sibley, Alexander B, Niedzwiecki, Donna, Venook, Alan P, Owzar, Kouros, Hurwitz, Herbert I, Nixon, Andrew B

Volltext

Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer von Shonibare, Zainab, Monavarian, Mehri, O’Connell, Kathleen, Altomare, Diego, Shelton, Abigail, Mehta, Shubham, Jaskula-Sztul, Renata, Phaeton, Rebecca, Starr, Mark D., Whitaker, Regina, Berchuck, Andrew, Nixon, Andrew B., Arend, Rebecca C., Lee, Nam Y., Miller, C. Ryan, Hempel, Nadine, Mythreye, Karthikeyan

Volltext

Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance) von Quintanilha, Julia C F, Sibley, Alexander B, Liu, Yingmiao, Niedzwiecki, Donna, Halabi, Susan, Rogers, Layne, O'Neil, Bert, Kindler, Hedy, Kelly, William, Venook, Alan, McLeod, Howard L, Ratain, Mark J, Nixon, Andrew B, Innocenti, Federico, Owzar, Kouros

Volltext

EGFR-Dependent IL8 Production by Airway Epithelial Cells After Exposure to the Food Flavoring Chemical 2,3-Butanedione von Kelly, Francine L, Weinberg, Kaitlyn E, Nagler, Andrew E, Nixon, Andrew B, Star, Mark D, Todd, Jamie L, Brass, David M, Palmer, Scott M

Volltext

Modulation of Circulating Protein Biomarkers in Cancer Patients Receiving Bevacizumab and the Anti-Endoglin Antibody, TRC105 von Liu, Yingmiao, Starr, Mark D, Brady, John C, Rushing, Christel, Pang, Herbert, Adams, Bonne, Alvarez, Delia, Theuer, Charles P, Hurwitz, Herbert I, Nixon, Andrew B

Volltext

The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients von Osada, Takuya, Chong, Gabriel, Tansik, Robert, Hong, Timothy, Spector, Neil, Kumar, Rakesh, Hurwitz, Herbert I., Dev, Inderjit, Nixon, Andrew B., Lyerly, H. Kim, Clay, Timothy, Morse, Michael A.

Volltext

Evaluating immune response and metabolic related biomarkers pre-allogenic hematopoietic stem cell transplant in acute myeloid leukemia von Siamakpour-Reihani, Sharareh, Cao, Felicia, Lyu, Jing, Ren, Yi, Nixon, Andrew B, Xie, Jichun, Bush, Amy T, Starr, Mark D, Bain, James R, Muehlbauer, Michael J, Ilkayeva, Olga, Byers Kraus, Virginia, Huebner, Janet L, Chao, Nelson J, Sung, Anthony D

Volltext

Plasma levels of angiopoietin-2, VEGF-A, and VCAM-1 as markers of bevacizumab-induced hypertension: CALGB 80303 and 90401 (Alliance) von Quintanilha, Julia C. F., Liu, Yingmiao, Etheridge, Amy S., Yazdani, Akram, Kindler, Hedy L., Kelly, William Kevin, Nixon, Andrew B., Innocenti, Federico

Volltext

Pilot investigation of circulating angiogenic and inflammatory biomarkers associated with vascular malformations von Wetzel-Strong, Sarah E, Weinsheimer, Shantel, Nelson, Jeffrey, Pawlikowska, Ludmila, Clark, Dewi, Starr, Mark D, Liu, Yingmiao, Kim, Helen, Faughnan, Marie E, Nixon, Andrew B, Marchuk, Douglas A

Volltext

A phase 2 trial of the somatostatin analog pasireotide to prevent GI toxicity and acute GVHD in allogeneic hematopoietic stem cell transplant von Ramalingam, Sendhilnathan, Siamakpour-Reihani, Sharareh, Bohannan, Lauren, Ren, Yi, Sibley, Alexander, Sheng, Jeff, Ma, Li, Nixon, Andrew B., Lyu, Jing, Parker, Daniel C., Bain, James, Muehlbauer, Michael, Ilkayeva, Olga, Kraus, Virginia Byers, Huebner, Janet L., Spitzer, Thomas, Brown, Jami, Peled, Jonathan U., van den Brink, Marcel, Gomes, Antonio, Choi, Taewoong, Gasparetto, Cristina, Horwitz, Mitchell, Long, Gwynn, Lopez, Richard, Rizzieri, David, Sarantopoulos, Stefanie, Chao, Nelson, Sung, Anthony D.

Volltext

Metastatic clear cell renal cell carcinoma: Circulating biomarkers to guide antiangiogenic and immune therapies von Zhang, Tian, M.D, Zhu, Jason, M.D, George, Daniel J., M.D, Nixon, Andrew B., Ph.D

Volltext

Effect of pazopanib on tumor microenvironment and liposome delivery von Tailor, Tina D, Hanna, Gabi, Yarmolenko, Pavel S, Dreher, Matthew R, Betof, Allison S, Nixon, Andrew B, Spasojevic, Ivan, Dewhirst, Mark W

Volltext

Glycosaminoglycan modifications of betaglycan regulate ectodomain shedding to fine-tune TGF-β signaling responses in ovarian cancer von Choi, Alex S, Jenkins-Lane, Laura M, Barton, Wade, Kumari, Asha, Lancaster, Carly, Raulerson, Calen, Ji, Hao, Altomare, Diego, Starr, Mark D, Whitaker, Regina, Phaeton, Rebecca, Arend, Rebecca, Shtutman, Michael, Nixon, Andrew B, Hempel, Nadine, Lee, Nam Y, Mythreye, Karthikeyan

Volltext

Effects of the combination of TRC105 and bevacizumab on endothelial cell biology von Liu, Yingmiao, Tian, Hongyu, Blobe, Gerard C., Theuer, Charles P., Hurwitz, Herbert I., Nixon, Andrew B.

Volltext